Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2013 On May 6, 2013

BOULDER, Colo., April 29, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:   ARRY) will report financial results for the third quarter of fiscal 2013 on Monday, May 6, 2013, and will hold a conference call on Tuesday, May 7, 2013 at 9:00 a.m. eastern time to discuss these results.  Ron Squarer, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.

Conference Call Information
Date: Tuesday, May 7, 2013
Time: 9:00 a.m. eastern time
Toll-Free: (800) 446-1671
Toll: (847) 413-3362
Pass Code: 34484588
Webcast & Conference Call Slides:  http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-irhome

A replay of the call will be available as a webcast on www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company with significant progress toward generating data to support its upcoming Phase 3 / pivotal trial decisions.  Novartis expects to begin Phase 3 trials evaluating Array-invented MEK162 in both NRAS- and BRAF-mutant melanoma in 2013.  AstraZeneca expects to begin Phase 3 or pivotal trials with Array-invented selumetinib in non-small cell lung cancer and thyroid cancer during the second half of 2013.  Three other Array invented drugs are also approaching Phase 3 / pivotal trial decisions by the end of 2013. These include Array's wholly-owned drugs, ARRY-520 and ARRY-614, and one partnered program, danoprevir (with InterMune/Roche).  For more information on Array, please go to www.arraybiopharma.com.

SOURCE Array BioPharma Inc.



RELATED LINKS
www.arraybiopharma.com

More by this Source

Best of Content We Love 2014 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.